Non-invasive Imaging Technique for the Study of Lordosis in Pregnant Women and Its Relationship to Birth Outcome
Launched by UNIVERSITY OF ALCALA · Jan 30, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to measure the curve of the spine, known as lordosis, in pregnant women and how this might relate to the outcomes of their deliveries. The researchers want to see if using a special imaging technique can help them understand the relationship between the spine's shape during pregnancy and how it affects childbirth. By collecting data from pregnant women, they hope to find patterns that can improve care for mothers and babies.
To participate in this study, women must be between 20 and 40 years old and have a low-risk pregnancy. Unfortunately, those under 20, over 40, or with certain health issues won't be eligible. If you join the study, you can expect to undergo non-invasive imaging to measure your spine's curvature, and your delivery outcome will be monitored as part of the research. This could lead to better insights into pregnancy and delivery, helping future mothers have healthier experiences.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • pregnant women between 20 and 40 years old with a low-risk pregnancy
- Exclusion Criteria:
- • Pregnant women under 20 years and over 40 years of age or with a significant lumbar pathology or with a very high-risk pregnancy or with IMC \>35
About University Of Alcala
The University of Alcalá, a prestigious institution located in Spain, is committed to advancing medical research and innovation through its clinical trial sponsorship. With a strong emphasis on interdisciplinary collaboration and ethical standards, the university leverages its academic expertise and state-of-the-art facilities to facilitate groundbreaking studies in various fields of healthcare. By fostering partnerships with industry leaders and healthcare professionals, the University of Alcalá aims to enhance patient outcomes and contribute to the global body of medical knowledge. Its dedication to rigorous research methodologies ensures the integrity and reliability of clinical trials, promoting a culture of excellence in scientific inquiry.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alcalá De Henares, Madrid, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials